Outcomes of reduction hepatectomy combined with postoperative multidisciplinary therapy for advanced hepatocellular carcinoma

Table 1 Clinical and surgical data

Clinical data			Surgical data
Age (yr)	62.8 ± 11.8		Anatomical hepatectomy	-	3
				+	27
Sex	Male	28	Operation time (min)	340
	Female	2
HBV/HCV	-	6	Blood loss (mL)	690
	+	24
Alb (g/dL)	3.71 ± 0.08		Number of tumors in the remnant liver	1-3	12
				≥ 4	18
T-Bil (mg/dL)	0.88 ± 0.08		POCR	+	8
				-	22
PT (%)	90.19 ± 2.75
ICGR15 (%)	17.34 ± 1.96
AFP (ng/mL)	102288 ± 7287
PIVKA-II (AU/mL)	52534 ± 22566
Child-pugh class	A	27
	B	3
Number of tumors	St	0
	Mt	30
Tumor size (cm)	10.13 ± 1.02
Differentiation	Wel	1
	Mod	16
	Por	13
pN	-	28
	+	2
Macrovascular invasion	-	5
	+	25
BCLC stage	B	12
	C	18
Distant metastasis	-	27
	+	3

PT: Prothrombin time; ICGR15: Indocyanine green retention rate at 15 min; AFP: Alpha-fetoprotein; PIVKA-II: Protein induced by vitamin K absence/antagonist-II; BCLC: Barcelona Clinic Liver Cancer.